ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.72
BATS BZX Real-Time Price
As of 11:16am ET
 +0.60 / +1.57%
Today’s Change
17.15
Today|||52-Week Range
46.48
+21.95%
Year-to-Date

Today’s Trading

Previous close38.12
Today’s open38.37
Day’s range38.11 - 38.75
Volume336,918
Average volume (3 months)2,123,371
Market cap$3.8B
Dividend yield--
Data as of 11:02am ET, 04/21/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-14.08%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book12.32

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.68+1.58%
IPXLImpax Laboratories I...-0.27-0.54%
GRFSGrifols SA+0.34+1.01%
ASPXAuspex Pharmaceutica...+0.02+0.02%
Data as of 11:17am ET, 04/21/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger M. Mills
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers